title: [Perspectives of the treatment of rheumatic diseases in the beginning of the XXI century].
abstract: Prevalence of immunoinflammatory diseases in general population is about 10%. Rheumatic diseases, first of all rheumatoid arthritis (RA), are among most prevalent immunoinflammatory diseases. In the first decade of the XXI century great progress was achieved in definition of the mechanisms of RA onset and in development of new approaches to its treatment. The article provides information about novel drugs which are effectively used not only in RA but also in other imunoinflammatory diseases.
authors.forename: E L
authors.initials: EL
authors.lastname: Nosonov
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D006801:Humans; D007113:Immunity, Innate; D015995:Prevalence; D012216:Rheumatic Diseases / Q000453:epidemiology / Q000276:immunology / Q000628:therapy; D012426:Russia / Q000453:epidemiology
chemical_list: D018501:Antirheumatic Agents